Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Cytomegalovirus

etoposide has been researched along with Cytomegalovirus in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blankenship, DW; Mauskar, MM; Nymeyer, H1
Arai, S; Blume, K; Brown, J; Johnston, L; Laport, G; Lowsky, R; Miklos, D; Naik, S; Negrin, R; Shizuru, J; Wong, R1
Cha, CY; Hwang, ES; Kim, J; Kim, JH; Kwon, YJ; Park, CG; Park, ES; Sung, B1
Attali, B; Bachelin, C; Baron-Van Evercooren, A; Chtarto, A; Girard, C; Lachapelle, F; Salvetti, A; Tenenbaum, L1
Cinatl, J; Doerr, HW; Driever, PH; Kabickova, H; Kornhuber, B; Kotchetkov, R; Schwabe, D; Vogel, JU1
Culić, S; Culić, V; Jakobson, A; Kuzmić, I; Primorac, D; Sćukanec-Spoljar, M1
Benson, JD; Huang, ES; Huong, SM; van der Horst, C; Wilson, B1

Other Studies

7 other study(ies) available for etoposide and Cytomegalovirus

ArticleYear
Cutaneous Ulcers Secondary to Cytomegalovirus and Herpes Simplex Virus in an Immunocompromised Patient.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Doxorubicin; Etoposide; Herpes Simplex; Humans; Immunocompromised Host; Male; Rituximab; Simplexvirus; Skin Ulcer

2017
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY.
    Bone marrow transplantation, 2011, Volume: 46, Issue:2

    Topics: Adult; Busulfan; Cyclophosphamide; Cytomegalovirus; Etoposide; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Middle Aged; Transplantation Conditioning; Treatment Outcome; Virus Activation

2011
Human cytomegalovirus (HCMV) IE1 plays role in resistance to apoptosis with etoposide in cancer cell line by Cdk2 accumulation.
    Microbiology and immunology, 2003, Volume: 47, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cytomegalovirus; DNA-Binding Proteins; Drug Resistance, Neoplasm; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Activation; Enzyme Inhibitors; Etoposide; Gene Expression Regulation; Humans; Immediate-Early Proteins; Purines; Roscovitine; Transcription Factors; Viral Proteins

2003
Efficiency of adeno-associated virus type-2 vectors in non-human primate Schwann cells.
    Neuroreport, 2005, Nov-07, Volume: 16, Issue:16

    Topics: Analysis of Variance; Animals; Cell Count; Cell Proliferation; Cell Transplantation; Cells, Cultured; Cytomegalovirus; Demyelinating Diseases; Dependovirus; Etoposide; Fibroblasts; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Hydroxyurea; Immunohistochemistry; Macaca fascicularis; Mice; Myelin Basic Protein; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Schwann Cells; Time Factors; Transduction, Genetic

2005
Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
    Cancer research, 1998, Jan-15, Volume: 58, Issue:2

    Topics: Antigens, Viral; Antineoplastic Agents; Antiviral Agents; Apoptosis; Blotting, Western; Cell Division; Cisplatin; Cytomegalovirus; DNA, Viral; Drug Resistance, Neoplasm; Etoposide; Ganciclovir; Genes, Viral; Humans; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Virus Replication

1998
Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
    Pediatric hematology and oncology, 2001, Volume: 18, Issue:4

    Topics: Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytomegalovirus; Etoposide; Female; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Infant; Interferon-alpha; Remission Induction; S100 Proteins

2001
Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection.
    Antiviral research, 1992, Volume: 17, Issue:1

    Topics: Amsacrine; Cell Division; Cell Line; Cell Survival; Cytomegalovirus; Cytomegalovirus Infections; DNA Damage; DNA Replication; DNA, Viral; Electrophoresis, Polyacrylamide Gel; Etoposide; Fibroblasts; Humans; Lung; Peptide Biosynthesis; Topoisomerase II Inhibitors; Virus Replication

1992